Related Experiment Video
Updated: Feb 10, 2026

High Content Screening in Neurodegenerative Diseases
Published on: January 6, 2012
Modulation of serine/threonine phosphatases by melatonin: therapeutic approaches in neurodegenerative diseases
Raquel L Arribas1, Alejandro Romero2, Javier Egea1,3,4
1Instituto-Fundación Teófilo Hernando, Departamento de Farmacología y Terapéutica, Universidad Autónoma de Madrid, Madrid, Spain.
Abstract:
Melatonin is an endogenous hormone produced by the pineal gland as well as many other tissues and organs. The natural decline in melatonin levels with ageing contributes significantly to the development of neurodegenerative disorders. Neurodegenerative diseases share common mechanisms of toxicity such as proteinopathy, mitochondrial dysfunction, metal dyshomeostasis, oxidative stress, neuroinflammation and an imbalance in the phosphorylation/dephosphorylation ratio. Several reports have proved the usefulness of melatonin in counteracting the events that lead to a neurodegenerative scenario. In this review, we have focused on the fact that melatonin could rectify the altered phosphorylation/dephosphorylation rate found in some neurodegenerative diseases by influencing the activity of phosphoprotein phosphatases. We analyse whether melatonin offers any protective activity towards these enzymes through a direct interaction. LINKED ARTICLES: This article is part of a themed section on Recent Developments in Research of Melatonin and its Potential Therapeutic Applications. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v175.16/issuetoc.
Insights
Melatonin decline with aging contributes to neurodegeneration. This review explores how melatonin may protect against neurodegenerative diseases by influencing phosphoprotein phosphatases and correcting altered phosphorylation rates.
Area of Science:
- Neuroscience
- Endocrinology
- Biochemistry
Background:
- Melatonin is an endogenous hormone with declining levels during aging.
- Aging-related melatonin reduction is linked to neurodegenerative disorders.
- Neurodegenerative diseases involve shared toxic mechanisms including proteinopathy and oxidative stress.
Purpose of the Study:
- To investigate melatonin's potential to rectify altered phosphorylation/dephosphorylation rates in neurodegenerative diseases.
- To analyze if melatonin directly interacts with and protects phosphoprotein phosphatases.
Main Methods:
- Literature review focusing on melatonin's role in neuroprotection.
- Analysis of studies investigating melatonin's influence on phosphoprotein phosphatase activity.
- Examination of direct interaction mechanisms between melatonin and these enzymes.
Main Results:
- Melatonin's decline is associated with neurodegenerative conditions.
- Melatonin shows potential in counteracting neurodegenerative pathways.
- Evidence suggests melatonin may influence phosphoprotein phosphatase activity.
Conclusions:
- Melatonin may offer neuroprotection by modulating phosphorylation/dephosphorylation balance.
- Direct interaction of melatonin with phosphoprotein phosphatases is a potential therapeutic mechanism.
- Further research is warranted to explore melatonin's therapeutic applications in neurodegenerative diseases.
Related Concept Videos
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein Kinases and Phosphatases
Therapeutic Index
Therapeutic Communication
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...
Microorganisms in Medicine and Therapeutics
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...

